Human Fibrin Sealant - Shandong Taibang Biological
Alternative Names: Fibrin SealantLatest Information Update: 28 Jul 2022
At a glance
- Originator Shandong Taibang Biological Products
- Developer China Biologic Products; Shandong Taibang Biological Products
- Class Acute-phase proteins; Adhesives; Antifibrinolytics; Antihaemorrhagics; Blood coagulation factors; Coagulants; Serine endopeptidases
- Mechanism of Action Fibrinogen replacements; Thrombin replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Surgical blood loss
Most Recent Events
- 28 Jul 2022 No recent reports of development identified for preclinical development in Surgical-blood-loss in China (Topical)
- 11 Jun 2018 Preclinical trials in Surgical blood loss in China (Topical) (Before June 2018)
- 11 Jun 2018 China Food and Drug Administration approves IND application for Human Fibrin Sealant in Surgical blood loss